Arrowhead Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ARWR

organization

Jurisdiction: US-DELegal Form: XTIQ

ACTIVE

LEI: 549300O3CSB8T7OZ3D66SIC: 2834

Also known as: ARROWHEAD PHARMACEUTICALS, INC.

SEC Insider

$245.5M

961 transactions

Summary

Arrowhead Pharmaceuticals, Inc. (ARWR) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.6MSales: $223.5M30 insiders

Date	Insider	Type	Value
2026-01-05	O'Brien Patrick(COO)	Sell	$847K
2026-01-05	O'Brien Patrick(COO)	Sell	$756K
2026-04-23	Hamilton James C(Chief Medical Officer)	Sell	$750K
2026-03-05	Hamilton James C(Chief Medical Officer)	Sell	$642K
2026-04-22	Apel Daniel Joseph(Chief Financial Officer)	Sell	$628K
2026-01-05	O'Brien Patrick(COO)	Sell	$384K
2026-01-05	O'Brien Patrick(COO)	Sell	$267K
2026-05-12	Lu Hongbo	Sell	$228K
2026-04-22	Apel Daniel Joseph(Chief Financial Officer)	Sell	$225K
2026-01-05	O'Brien Patrick(COO)	Sell	$174K
2026-04-22	Apel Daniel Joseph(Chief Financial Officer)	Sell	$82K
2026-06-15	Cohen Matthew Gregory	A	$0
2026-01-06	O'Brien Patrick(COO)	G	$0
2026-01-06	O'Brien Patrick(COO)	G	$0
2026-01-06	O'Brien Patrick(COO)	G	$0
2026-01-06	O'Brien Patrick(COO)	G	$0
2026-01-06	O'Brien Patrick(COO)	G	$0
2026-01-06	O'Brien Patrick(COO)	A	$0
2026-01-06	Hamilton James C(Chief Medical Officer)	A	$0
2026-01-06	Apel Daniel Joseph(Chief Financial Officer)	A	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Arrowhead Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope